Peregrine Pharmaceuticals reported $31.35M in Trade Debtors for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Debtors Change
Agenus AGEN:US $ 1.29M 0.23M
Amgen AMGN:US $ 5077M 182M
AstraZeneca AZN:LN 9.05B 1.26B
Biocryst Pharmaceuticals BCRX:US $ 36.42M 7M
Bristol Myers Squibb BMY:US $ 8511M 858M
Celldex Therapeutics CLDX:US $ 0.24M 0.07M
Chemocentryx CCXI:US $ 2.81M 2.36M
Eli Lilly And LLY:US $ 7805.7M 321.5M
GlaxoSmithKline GSK:LN 8.8B 451M
Immunogen IMGN:US $ 10.25M 3.68M
Intrexon XON:US $ 24.87M 3.4M
Karyopharm Therapeutics KPTI:US $ 24.99M 2.5M
Macrogenics MGNX:US $ 14.9M 4.52M
Mannkind MNKD:US $ 9.82M 4.83M
Merk MRK:US $ 9828M 598M
Newlink Genetics NLNK:US 134K 6K
Novartis NOVN:VX 8.68B 395M
Novavax NVAX:US $ 478.16M 23.16M
Peregrine Pharmaceuticals PPHM:US $ 31.35M 9.8M
Repligen RGEN:US $ 122.44M 5.01M
Xencor XNCR:US $ 93.2M 26.82M